Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LAMTOR3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PIK3CA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMU1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GTSE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ITPKB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ITGB1BP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FRYL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BRCC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRPF4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HCCS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
JMY - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ALDH16A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
S1PR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYP2U1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEPSECS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YY1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC16A10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC30A5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DXO - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STX17 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on